Condition
Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface|Malignant Peritoneal Mesothelioma|Peritoneal Carcinomatosis
Estimated Enrollment: 168
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: No masking|Primary Purpose: Treatment
Study ID Numbers: 12-110|5P01CA132714-05
Study First Received: May 28, 2014
Last Updated: February 2, 2017
Estimated Primary Completion Date: December 2017
Primary Outcome Measures:
Number of participants with adverse events|Time to disease progression|How long participants live after surgery|Changes in the immune system
Sponsors and Collaborators:
Pawel Kalinski|National Cancer Institute (NCI)|University of Pittsburgh
Website Link: https://ClinicalTrials.gov/show/NCT02151448
